• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

116.67 +0.03 (+0.03%)
Official Closing Price Updated: 7:00 PM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,917,081
Open 116.28
Bid (Size) 116.36 (600)
Ask (Size) 117.58 (100)
Prev. Close 116.64
Today's Range 115.82 - 117.34
52wk Range 81.97 - 137.49
Shares Outstanding 1,750,942,289
Dividend Yield 2.16%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead. ↗
Today 10:35 EDT
AbbVie and Abbott stand out as strong healthcare investments because they combine established businesses with long-term growth opportunities. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? ↗
August 23, 2026
These two high-quality dividend payers have had very different fortunes recently. 
Via The Motley Fool
Topics Lawsuit

Performance

YTD
-6.1%
-6.1%
1 Month
+11.7%
+11.7%
3 Month
+34.6%
+34.6%
6 Month
+1.2%
+1.2%
1 Year
-11.5%
-11.5%

More News

Read More
News headline image
Recent Report Shows That Rep. Rick Allen Sold Up to $50K Worth of Abbott Laboratories Stock ↗
August 19, 2026
Via Benzinga
Abbott Laboratories (NYSE:ABT): A Strong Candidate for Quality Investors ↗
July 30, 2026
Via Chartmill
News headline image
If You Invest $100 a Month in SCHD, Here's the Passive Income It Could Deliver in 20 Years ↗
August 17, 2026
Via The Motley Fool
Topics ETFs Retirement Stocks
News headline image
Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock ↗
August 17, 2026
Via Benzinga
News headline image
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗
August 16, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Recession-Proofing Your Portfolio Before the Storm Hits ↗
August 13, 2026
Via The Motley Fool
Topics Economy
News headline image
The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a Recession ↗
August 11, 2026
Via The Motley Fool
Topics Economy
News headline image
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? ↗
August 11, 2026
Via The Motley Fool
News headline image
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026? ↗
August 07, 2026
Via The Motley Fool
News headline image
Solventum Nears Inflection Point As It Begins to Unlock Value ↗
August 07, 2026
Via MarketBeat
Topics Initial Public Offering
News headline image
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now ↗
August 05, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? ↗
August 02, 2026
Via The Motley Fool
News headline image
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
July 31, 2026
Via The Motley Fool
News headline image
3 Dividend Stocks to Buy for a Lifetime of Passive Income ↗
July 29, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now? ↗
July 29, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Wall Street Can't Get Enough of This Dividend King ↗
July 25, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow ↗
July 21, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? ↗
July 19, 2026
Via The Motley Fool
News headline image
My 2 Favorite Dividend Kings to Buy Right Now ↗
July 19, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
This Dividend ETF Yields 3.2% and Is Beating the Nasdaq-100 This Year ↗
July 18, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results ↗
July 17, 2026
Via Benzinga
News headline image
Why Abbott Stock Jumped Today ↗
July 16, 2026
Via The Motley Fool
Explore the top gainers and losers within the S&P500 index in today's session. ↗
July 16, 2026
Via Chartmill

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 116.67
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 08/24/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 204.28B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 204B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap